CCL2 and depressive symptom measurement: Higher levels of MCP-1 were associated with poorer sleep (Figure 4A, p = 0.004), higher scores of anxiety (Figure 4B, p = 0.006) and higher scores of depression (Figure 4C, p < 0.002).